Portage Biotech Inc expected to post a loss of 27 cents a share - Earnings Preview

Alpha Compute

28/07/2023 16:01

* Portage Biotech Inc  PRTG.OQ   PRTG.O  is expected to show
no
change in quarterly revenue when it reports  results on July 31
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Portage Biotech Inc
is
for a loss of 27 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Portage
Biotech
Inc is $18.5​, above​ its last closing price of $2.76. ​​​

This summary was machine generated July 28 at 15:01 GMT.  All
figures in US dollars  unless otherwise stated